ArtiQ

Belgium
Leuven, Flanders, Belgium, 3000

Company profile

ArtiQ company profile

ArtiQ is a young, dynamic and innovative spin-off company of the University of Leuven (Belgium). Company is founded in early 2019 by four committed founders with a long history in respiratory medicine, medical devices and artificial intelligence. Working on a junction of multidisciplinary fields, founders identified opportunity and value that novel technologies could bring to all parties in a respiratory setting: patients, doctors, healthcare system and industry. ArtiQ aims to become the trusted partner of medical practitioners for the diagnosis, treatment, and follow-up of respiratory problems. With the first developed artificial intelligence-based medical software, ArtiQ is already helping interpretation of pulmonary function tests and improving lung disease diagnostic environment.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-02-07

Headquarters

Postal code
3000
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Total equity funding
$1.1M
Last funding
Seed / $1.1M / 2019-07-15
Last equity funding
Seed / $1.1M
Investors
2
Lead investors
2
Founders
1
Articles
7
Exited on
2024-04-02

Founders and investors

Founders

Marko Topalovic

Lead investors

Gemma Frisius FundKBC

Investors

Gemma Frisius FundKBC